Ewing Sarcoma: Trabectedin & Irinotecan Target EWS::FLI1
New Drug Combination Marks Ewing Sarcoma Treatment Breakthrough in Phase 1/2 Trial In a pivotal shift for pediatric and adolescent oncology, a new therapeutic strategy is showing remarkable promise in treating one of the most challenging bone cancers. Researchers have unveiled a potent combination therapy targeting the genetic engine of Ewing sarcoma, yielding what experts … Read more